Pretreatment prediction of individual rheumatoid arthritis patients' response to anti-cytokine therapy using serum cytokine/chemokine/soluble receptor biomarkers

Uno Kazuko; Yoshizaki Kazuyuki; Iwahashi Mitsuhiro; Tanigawa Mild; Yagi Katsumi

首页> 外文期刊>Cytokine >Pretreatment prediction of individual rheumatoid arthritis patients' response to anti-cytokine therapy using serum cytokine/chemokine/soluble receptor biomarkers

【24h】

Pretreatment prediction of individual rheumatoid arthritis patients' response to anti-cytokine therapy using serum cytokine/chemokine/soluble receptor biomarkers

机译：使用血清细胞因子/趋化因子/可溶性受体生物标记物预测类风湿关节炎患者对抗细胞因子治疗的反应

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cytokine》 |2015年第1期|共1页
作者
Uno Kazuko; Yoshizaki Kazuyuki; Iwahashi Mitsuhiro; Tanigawa Mild; Yagi Katsumi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类细胞生物学;
关键词

相似文献

外文文献
中文文献
专利

1. Pretreatment prediction of individual rheumatoid arthritis patients' response to anti-cytokine therapy using serum cytokine/chemokine/soluble receptor biomarkers [J] . Uno Kazuko, Yoshizaki Kazuyuki, Iwahashi Mitsuhiro, Cytokine . 2015,第1期

机译：使用血清细胞因子/趋化因子/可溶性受体生物标记物预测类风湿关节炎患者对抗细胞因子治疗的反应
2. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy [J] . Sakamoto Noriho, Hara Shintaro, Ishimoto Hiroshi, The Tohoku Journal of Experimental Medicine . 2019,第3期

机译：血清可溶性白细胞介素-2受体是甲氨蝶呤治疗下的类风湿性关节炎患者的肺炎肺炎肠道肺炎的生物标志物
3. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis [J] . T.Robak, A.Gladalska, H.Stepień, Mediators of inflammation . 1998,第5期

机译：类风湿关节炎患者血清白细胞介素6型细胞因子和可溶性白细胞介素6受体水平
4. From Discovery to Validation: Rheumatoid Arthritis Serum Protein Biomarkers by Multiple Reaction Monitoring [C] . Shanhua Lin, Hua Lin, Ted Jones, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2009

机译：从发现到验证：多重反应监测的类风湿性关节炎血清蛋白生物标志物
5. Serum and Fecal Biomarkers Predict Response to Infliximab Therapy in Pediatric Patients with Inflammatory Bowel Disease [D] . Kim, Jochebed. 2020

机译：血清和粪便生物标志物预测对炎症肠病小儿患者的英夫利昔单抗疗法的反应
6. Pretreatment Prediction of Individual Rheumatoid Arthritis Patients’ Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers [O] . Kazuko Uno, Kazuyuki Yoshizaki, Mitsuhiro Iwahashi, -1

机译：使用血清细胞因子/趋化因子/可溶性受体生物标记物对类风湿关节炎患者对抗细胞因子治疗的反应进行预处理预测
7. Pretreatment Prediction of Individual Rheumatoid Arthritis Patients' Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers. [O] . Kazuko Uno, Kazuyuki Yoshizaki, Mitsuhiro Iwahashi, 2015

机译：使用血清细胞因子/趋化因子/可溶性受体生物标志物预处理个体类风湿性关节炎患者对抗细胞因子治疗的反应。

Pretreatment prediction of individual rheumatoid arthritis patients' response to anti-cytokine therapy using serum cytokine/chemokine/soluble receptor biomarkers

著录项

相似文献

相关主题

期刊订阅